| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | -82.5% |
| R&D Expense | $35.3M | -47.5% |
| SG&A Expense | $17.2M | -9.7% |
| Operating Income | -$51.5M | +36.1% |
| Income Tax | $0 | — |
| Net Income | -$48.8M | +35.3% |
| EPS (Basic) | -$0.70 | +53.0% |
| EPS (Diluted) | -$0.70 | +53.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.2M | -5.6% |
| Current Assets | $82.5M | +4.1% |
| Total Assets | $91.0M | -0.0% |
| Current Liabilities | $7.1M | -20.9% |
| Total Liabilities | $8.6M | -24.4% |
| Stockholders' Equity | $82.4M | +3.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.9M | +34.1% |
| Capital Expenditures | $71K | +20.3% |
| Investing Cash Flow | -$7.9M | +7.3% |
| Financing Cash Flow | $44.6M | +5563.8% |
| Free Cash Flow | -$40.0M | +34.0% |